These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Lipid-lowering drugs. Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443 [No Abstract] [Full Text] [Related]
45. A pathophysiologic approach to managing hyperlipemia. Hazzard WR Am Fam Physician; 1976 Aug; 14(2):78-87. PubMed ID: 941821 [TBL] [Abstract][Full Text] [Related]
46. [Hyperlipoproteinemia and atherosclerosis as a problem for the pediatrician]. Turcanu L; Micle I; Tomoşoiu O Rev Pediatr Obstet Ginecol Pediatr; 1975; 24(2):105-14. PubMed ID: 810851 [No Abstract] [Full Text] [Related]
47. Results of treatment of hyperlipidemias: long-term compliance and effect of lipid metabolism. Frantz ID Adv Exp Med Biol; 1977; 82():649-55. PubMed ID: 920422 [No Abstract] [Full Text] [Related]
48. [Hyperlipidemias. Diet and drug therapy]. Sailer S ZFA (Stuttgart); 1977 Oct; 53(30):1829-33. PubMed ID: 930271 [No Abstract] [Full Text] [Related]
49. Therapy of hyperlipidemic states. Havel RJ; Kane JP Annu Rev Med; 1982; 33():417-33. PubMed ID: 7044276 [No Abstract] [Full Text] [Related]
50. [Antilipemic agents available after the ban on clofibrate: clinical-pharmacological view]. Mertz DP Fortschr Med; 1979 Apr; 97(15):695-6, 698. PubMed ID: 456970 [TBL] [Abstract][Full Text] [Related]
51. Hyperlipidemia: to treat or not to treat. Parsons WB Ariz Med; 1975 Apr; 32(4):323-8. PubMed ID: 1119953 [No Abstract] [Full Text] [Related]
52. [Indications, contraindications and adverse effects of drugs in cardiovascular diseases. Treatment of hyperlipoproteinemia]. Marek H; Kuklinski B; Hunger R Z Arztl Fortbild (Jena); 1977 Apr; 71(8):389-92. PubMed ID: 878508 [No Abstract] [Full Text] [Related]
53. [Hyperlipoproteinemias in internal medicine and therapeutic possibilities]. Kubasta M; Vaverková H Cas Lek Cesk; 1975 Mar; 114(10-11):330-4. PubMed ID: 1139580 [No Abstract] [Full Text] [Related]
54. [Medical treatment of hyperlipemia. Indications and modern preparations]. Frey H Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311 [No Abstract] [Full Text] [Related]
55. Control of biochemical precursors of coronary heart disease. Ostrander LD Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631 [No Abstract] [Full Text] [Related]
56. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs]. Haacke H; Kolenda KD Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999 [No Abstract] [Full Text] [Related]
57. [Hyperlipoproteinemia type II]. Schade RW Ned Tijdschr Geneeskd; 1980 Dec; 124(51):2172-81. PubMed ID: 6782494 [No Abstract] [Full Text] [Related]
58. Treatment of hyperlipidemic states. Strisower EH; Adamson G; Strisower B Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683 [No Abstract] [Full Text] [Related]
59. Management of the hyperlipidaemias. Drug Ther Bull; 1980 Mar; 18(7):25-8. PubMed ID: 7371502 [No Abstract] [Full Text] [Related]
60. [Treatment of hyperlipoproteinemia]. Creţeanu G; Lacatîş D Rev Med Chir Soc Med Nat Iasi; 1978; 82(2):309-18. PubMed ID: 705131 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]